Search research articles
Contact Us
Filters
Showing results (41-50 of 63) with videos related to
Page
of 7
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases
|
May 14, 2013
Impact of pretransplant donor and recipient cytomegalovirus serostatus on outcome for multiple myeloma patients undergoing reduced intensity conditioning allogeneic stem cell transplantation
Jean El-Cheikh, Raynier Devillier, Roberto Crocchiolo, et al.
Bulletin Du Cancer
|
July 6, 2022
[Method and impact of allografts cryopreservation during the Covid-19 pandemic: guidelines from the SFGM-TC]
Edouard Forcade, Solenn Bacquet, Caroline Ballot, et al.
European Journal of Haematology
|
March 6, 2012
Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma
Jean El-Cheikh, Roberto Crocchiolo, Jean-Marie Boher, et al.
Bulletin Du Cancer
|
May 9, 2026
[Storage and disposal of cryopreserved cellular products and associated samples (SFGM-TC)]
Justine Nasone, Caroline Ballot, Ulrick Birba, et al.
Bulletin Du Cancer
|
December 25, 2018
[Donor Lymphocyte Infusions (DLI): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]
John De Vos, Etienne Baudoux, Jacques-Olivier Bay, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 11, 2013
CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies
Evgeny Klyuchnikov, Jean El-Cheikh, Andreas Sputtek, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 27, 2016
Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation
Laurys Boudin, Christian Chabannon, Patrick Sfumato, et al.
Bulletin Du Cancer
|
July 17, 2025
[End of COBE2991®: What alternatives are available for the preparation of each type of cell therapy products? (SFGM-TC)]
Justine Nasone, Carina Alves Goncalves, Caroline Ballot, et al.
Journal of Cancer
|
November 24, 2016
Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study
Laurys Boudin, Anthony Gonçalves, Patrick Sfumato, et al.
Bulletin Du Cancer
|
February 19, 2017
[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience]
Laurys Boudin, Christian Chabannon, Patrick Sfumato, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 63) with videos related to
Sort By:
Page
of 7
Mediterranean Journal of Hematology and Infectious Diseases
|
May 14, 2013
Impact of pretransplant donor and recipient cytomegalovirus serostatus on outcome for multiple myeloma patients undergoing reduced intensity conditioning allogeneic stem cell transplantation
Jean El-Cheikh, Raynier Devillier, Roberto Crocchiolo, et al.
Bulletin Du Cancer
|
July 6, 2022
[Method and impact of allografts cryopreservation during the Covid-19 pandemic: guidelines from the SFGM-TC]
Edouard Forcade, Solenn Bacquet, Caroline Ballot, et al.
European Journal of Haematology
|
March 6, 2012
Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma
Jean El-Cheikh, Roberto Crocchiolo, Jean-Marie Boher, et al.
Bulletin Du Cancer
|
May 9, 2026
[Storage and disposal of cryopreserved cellular products and associated samples (SFGM-TC)]
Justine Nasone, Caroline Ballot, Ulrick Birba, et al.
Bulletin Du Cancer
|
December 25, 2018
[Donor Lymphocyte Infusions (DLI): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]
John De Vos, Etienne Baudoux, Jacques-Olivier Bay, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 11, 2013
CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies
Evgeny Klyuchnikov, Jean El-Cheikh, Andreas Sputtek, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 27, 2016
Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation
Laurys Boudin, Christian Chabannon, Patrick Sfumato, et al.
Bulletin Du Cancer
|
July 17, 2025
[End of COBE2991®: What alternatives are available for the preparation of each type of cell therapy products? (SFGM-TC)]
Justine Nasone, Carina Alves Goncalves, Caroline Ballot, et al.
Journal of Cancer
|
November 24, 2016
Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study
Laurys Boudin, Anthony Gonçalves, Patrick Sfumato, et al.
Bulletin Du Cancer
|
February 19, 2017
[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience]
Laurys Boudin, Christian Chabannon, Patrick Sfumato, et al.
Page
of 7